P/E ratio for Medicare Group (MCGS.QA)
P/E ratio as of May 2024 (TTM): 15.5
According to Medicare Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.5102. At the end of 2022 the company had a P/E ratio of 22.2.
P/E ratio history for Medicare Group from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 22.2 | -26.95% |
| 2021 | 30.4 | 2.79% |
| 2020 | 29.5 | -1.81% |
| 2019 | 30.1 | 42.79% |
| 2018 | 21.1 | -14.37% |
| 2017 | 24.6 | -9.67% |
| 2016 | 27.2 | 44.01% |
| 2015 | 18.9 | 5.96% |
| 2014 | 17.8 | 7.88% |
| 2013 | 16.5 | -25.07% |
| 2012 | 22.1 | 25.5% |
| 2011 | 17.6 | 57.43% |
| 2010 | 11.2 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.